Skip main navigation
Close Drawer MenuOpen Drawer Menu

The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Back to table of contents
New ResearchFull Access

Methamphetamine Use and Schizophrenia: A Population-Based Cohort Study in California

Published Online:1 Apr 2012https://doi.org/10.1176/appi.ajp.2011.10070937

References

  • 1. Minozzi S: An overview of systematic reviews on cannabis and psychosis: discussing apparently conflicting results. Drug Alcohol Rev 2010; 29:304–317 Crossref, Medline, Google Scholar
  • 2. Zorick TS , Rad D , Rim C , Tsuang J: An overview of methamphetamine-induced psychotic syndromes. Addict Disord Their Treat 2008; 7:143–156 Crossref, Google Scholar
  • 3. Sato M , Numachi Y , Hamamura T: Relapse of paranoid psychotic state in methamphetamine model of schizophrenia. Schizophr Bull 1992; 18:115–122 Crossref, Medline, Google Scholar
  • 4. Angrist B: Amphetamine psychosis: clinical variations of the syndrome, in Amphetamine and Its Analogs: Pharmacology, Toxicology, and Abuse. Edited by Cho AKSegal DS. New York, Academic Press, 1994, pp 387–411 Google Scholar
  • 5. Grelotti DJ , Kanayama G , Pope HG: Remission of persistent methamphetamine-induced psychosis after electroconvulsive therapy: presentation of a case and review of the literature. Am J Psychiatry 2010; 167:17–23 Link, Google Scholar
  • 6. Flaum M , Schultz SK: When does amphetamine-induced psychosis become schizophrenia? Am J Psychiatry 1996; 153:812–815 Link, Google Scholar
  • 7. van Winkel R , Stefanis NC , Myin-Germeys I: Psychosocial stress and psychosis: a review of the neurobiological mechanisms and the evidence for gene-stress interaction. Schizophr Bull 2008; 34:1095–1105 Crossref, Medline, Google Scholar
  • 8. Zach A: New Way to Edit: Discharge Data Review. Sacramento, California Office of Statewide Health Planning and Development, 1990 Google Scholar
  • 9. California Office of Statewide Health Planning and Development: Editing Criteria Handbook. Sacramento, 1995 Google Scholar
  • 10. California Office of Statewide Health Planning and Development: Report of the Results From OSHPD Reabstracting Project: An Evaluation of the Reliability of Selected Patient Discharge Data, July Through December 1988. Sacramento, 1990 Google Scholar
  • 11. Rawson NS , Malcolm E , D'Arcy C: Reliability of the recording of schizophrenia and depressive disorder in the Saskatchewan health care datafiles. Soc Psychiatry Psychiatr Epidemiol 1997; 32:191–199 Crossref, Medline, Google Scholar
  • 12. Schwartz AH , Perlman BB , Paris M , Schmidt K , Thornton JC: Psychiatric diagnoses as reported to Medicaid and as recorded in patient charts. Am J Public Health 1980; 70:406–408 Crossref, Medline, Google Scholar
  • 13. Kashner TM: Agreement between administrative files and written medical records: a case of the Department of Veterans Affairs. Med Care 1998; 36:1324–1336 Crossref, Medline, Google Scholar
  • 14. Hale DA , Molloy M , Pearl RH , Schutt DC , Jaques DP: Appendectomy: a contemporary appraisal. Ann Surg 1997; 225:252–261 Crossref, Medline, Google Scholar
  • 15. Sauerland S , Lefering R , Neugebauer EA: Laparoscopic versus open surgery for suspected appendicitis. Cochrane Database Syst Rev 2004; 4:CD001546 Medline, Google Scholar
  • 16. Callaghan RC , Cunningham JK , Sajeev G , Kish SJ: Incidence of Parkinson's disease among hospital patients with methamphetamine-use disorders. Mov Disord 2010; 25:2333–2339 Crossref, Medline, Google Scholar
  • 17. Lin HC , Hsiao FH , Pfeiffer S , Hwang YT , Lee HC: An increased risk of stroke among young schizophrenia patients. Schizophr Res 2008; 101:234–241 Crossref, Medline, Google Scholar
  • 18. McGrath J , Saha S , Welham J , El Saadi O , MacCauley C , Chant D: A systematic review of the incidence of schizophrenia: the distribution of rates and the influence of sex, urbanicity, migrant status, and methodology. BMC Med 2004; 2:13 Crossref, Medline, Google Scholar
  • 19. US Department of Health and Human Services, Substance Abuse and Mental Health Data Archive: Treatment Episode Data Set: Admissions (TEDS-A), concatenated, 1992 to 2008 (computer file ICPSR25221-v2.2011) Google Scholar
  • 20. Cunningham JK , Liu LM: Impacts of federal ephedrine and pseudoephedrine regulations on methamphetamine-related hospital admissions. Addiction 2003; 98:1229–1237 Crossref, Medline, Google Scholar
  • 21. D'Agostino RB , D'Agostino RB: Estimating treatment effects using observational data. JAMA 2007; 297:314–316 Crossref, Medline, Google Scholar
  • 22. D'Agostino RB: Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 1998; 17:2265–2281 Crossref, Medline, Google Scholar
  • 23. Charlson ME , Pompei P , Ales KL , MacKenzie CR: A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40:373–383 Crossref, Medline, Google Scholar
  • 24. Austin PC , Mamdani MM: A comparison of propensity score methods: a case-study estimating the effectiveness of post-AMI statin use. Stat Med 2006; 25:2084–2106 Crossref, Medline, Google Scholar
  • 25. Austin PC: Propensity-score matching in the cardiovascular surgery literature from 2004 to 2006: a systematic review and suggestions for improvement. J Thorac Cardiovasc Surg 2007; 134:1128–1135 Crossref, Medline, Google Scholar
  • 26. Shah BR , Laupacis A , Hux JE , Austin PC: Propensity score methods gave similar results to traditional regression modeling in observational studies: a systematic review. J Clin Epidemiol 2005; 58:550–559 Crossref, Medline, Google Scholar
  • 27. Macleod J , Oakes R , Oppenkowski T , Stokes-Lampard H , Copello A , Crome I , Smith GD , Egger M , Hickman M , Judd A: How strong is the evidence that illicit drug use by young people is an important cause of psychological or social harm? methodological and policy implications of a systematic review of longitudinal, general population studies. Drugs Educ Prevent Policy 2004; 11:281–297 Crossref, Google Scholar
  • 28. Zammit S , Allebeck P , Andreasson S , Lundberg I , Lewis G: Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study. BMJ 2002; 325:1199 Crossref, Medline, Google Scholar
  • 29. Ujike H , Sato M: Clinical features of sensitization to methamphetamine observed in patients with methamphetamine dependence and psychosis. Ann NY Acad Sci 2004; 1025:279–287 Crossref, Medline, Google Scholar
  • 30. Konuma K: Use and abuse of amphetamines in Japan, in Amphetamine and Its Analogs: Pharmacology, Toxicology, and Abuse. Edited by Cho AKSegal DS. New York, Academic Press, 1994, pp 415–435 Google Scholar
  • 31. Sturmer T , Joshi M , Glynn RJ , Avorn J , Rothman KJ , Schneeweiss S: A review of the application of propensity score methods yielded increasing use, advantages in specific settings, but not substantially different estimates compared with conventional multivariable methods. J Clin Epidemiol 2006; 59:437–447 Crossref, Medline, Google Scholar
  • 32. Jansson LB , Parnas J: Competing definitions of schizophrenia: what can be learned from polydiagnostic studies? Schizophr Bull 2007; 33:1178–1200 Crossref, Medline, Google Scholar
  • 33. Thompson JW , Pincus H: A crosswalk from DSM-III-R to ICD-9-CM. Am J Psychiatry 1989; 146:1315–1319 Link, Google Scholar
  • 34. Lieberman JA , Sheitman BB , Kinon BJ: Neurochemical sensitization in the pathophysiology of schizophrenia: deficits and dysfunction in neuronal regulation and plasticity. Neuropsychopharmacology 1997; 17:205–229 Crossref, Medline, Google Scholar
  • 35. Welch KA , McIntosh AM , Job DE , Whalley HC , Moorhead TW , Hall J , Owens DG , Lawrie SM , Johnstone EC: The impact of substance use on brain structure in people at high risk of developing schizophrenia. Schizophr Bull 2011; 37:1066–1076 Crossref, Medline, Google Scholar
  • 36. van Os J , Rutten BP , Poulton R: Gene-environment interactions in schizophrenia: review of epidemiological findings and future directions. Schizophr Bull 2008; 34:1066–1082 Crossref, Medline, Google Scholar
  • 37. National Institute for Clinical Excellence (NICE): Schizophrenia: Core Interventions in the Treatment and Management of Schizophrenia in Adults in Primary and Secondary Care. London, NICE, 2009 Google Scholar
  • 38. Rounsaville BJ: DSM-V research agenda: substance abuse/psychosis comorbidity. Schizophr Bull 2007; 33:947–952 Crossref, Medline, Google Scholar